Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review

被引：1

作者：

Guglielmo, Priscilla ^{[1
,2
]}

Buffi, Nicolo ^{[2
,3
]}

Porreca, Angelo ^{[4
]}

Setti, Lucia ^{[1
]}

Arico, Demetrio ^{[5
]}

Muraglia, Lorenzo ^{[6
]}

Evangelista, Laura ^{[2
,6
]}

机构：

[1] Nucl Med Unit, Human Gavazzeni, Bergamo, Italy

[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[3] IRCCS, Dept Urol, Humanitas Clin & Res Inst, Rozzano, Italy

[4] Veneto Inst Oncol IOV IRCCS, Dept Oncol Urol, Padua, Italy

[5] Humanitas Oncol Ctr Catania, Dept Nucl Med, I-95125 Catania, Italy

[6] Humanitas Clin & Res Inst IRCCS, Nucl Med Unit, Rozzano, Italy

来源：

ANNALS OF NUCLEAR MEDICINE | 2025年 / 39卷 / 03期

关键词：

Intermediate risk; Prostate cancer; PSMA PET; Lymph node involvement; SUVmax; THERAPY;

D O I：

10.1007/s12149-025-02015-w

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The purpose of this systematic review was to evaluate the role of PSMA PET/CT in intermediate-risk prostate cancer (PCa) patients, to determine whether it could help improve treatment strategy and prognostic stratification. A systematic literature search up to May 2024 was conducted in the PubMed, Embase and Scopus databases. Articles with mixed risk patient populations, review articles, editorials, letters, comments, or case reports were excluded. The quality of the papers was assessed by using the CASP criteria. The literature search returned 1111 studies; however, 1105 articles were excluded, and therefore 6 full-text papers were retrieved for the final analysis. Three out of six papers focused on the utility of SUVmax in identifying high ISUP grade in patients with intermediate-risk PCa. The latest three papers discussed the controversial role of PSMA PET/CT in predicting the lymph node involvement, mainly in the case of favorable subset. PSMA PET has completely changed the management of patients with PCa; indeed its role is still undefined in patients with intermediate-risk disease. Future perspective is to investigate larger cohorts of intermediate-risk PCa patients, to fully recognize the added value offered by PSMA PET in this category of subjects.

引用

页码：247 / 254

页数：8

共 41 条

[11] Rates of advanced prostate cancer continue to increase [J].

Fillon, Mike .

CA-A CANCER JOURNAL FOR CLINICIANS, 2020, 70 (06) :427-429

[12] Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature [J].

Futterer, Jurgen J. ;

Briganti, Alberto ;

De Visschere, Pieter ;

Emberton, Mark ;

Giannarini, Gianluca ;

Kirkham, Alex ;

Taneja, Samir S. ;

Thoeny, Harriet ;

Villeirs, Geert ;

Villers, Arnauld .

EUROPEAN UROLOGY, 2015, 68 (06) :1045-1053

[13]

Gillessen S., 2024, EUR UROL, VS03022838, P02610

[14] Additional Value of PET Radiomic Features for the Initial Staging of Prostate Cancer: A Systematic Review from the Literature [J].

Guglielmo, Priscilla ;

Marturano, Francesca ;

Bettinelli, Andrea ;

Gregianin, Michele ;

Paiusco, Marta ;

Evangelista, Laura .

CANCERS, 2021, 13 (23)

[15] The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer [J].

Hagens, Marinus J. ;

Luining, Wietske I. ;

Jager, Auke ;

Donswijk, Maarten L. ;

Cheung, Zing ;

Wondergem, Maurits ;

Oprea-Lager, Daniela E. ;

Vis, Andre N. ;

van Leeuwen, Pim J. ;

van der Poel, Henk G. .

JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (08) :1238-1243

[16] Expanding the role of PSMA PET in active surveillance [J].

Jain, Anika ;

Nassour, Anthony-Joe ;

Dean, Thomas ;

Patterson, Imogen ;

Tarlinton, Lisa ;

Kim, Lawrence ;

Woo, Henry .

BMC UROLOGY, 2023, 23 (01)

[17] [18F]-PSMA-1007 PET imaging optimization and inter-rater reliability - a comparison of three different reconstructions read by four radiologists [J].

Jonmarker, Olof ;

Nilsson, Ted ;

Axelsson, Rimma ;

Ericson, Lovisa Hult ;

Tran, Thuy A. ;

Tzortzakakis, Antonios ;

Savitcheva, Irina ;

Holstensson, Maria .

NUCLEAR MEDICINE COMMUNICATIONS, 2024, 45 (05) :389-395

[18] 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography-Based Primary Staging and Histological Correlation after Extended Pelvic Lymph Node Dissection in Intermediate-Risk Prostate Cancer [J].

Kopp, Daniela ;

Kopp, Johannes ;

Bernhardt, Eugen ;

Manka, Lukas ;

Beck, Andreas ;

Gerullis, Holger ;

Karakiewicz, Pierre I. ;

Salomon, Georg ;

Wiggermann, Philipp ;

Hammerer, Peter ;

Schiffmann, Jonas .

UROLOGIA INTERNATIONALIS, 2022, 106 (01) :56-62

[19] Diagnostic and therapeutic impact of PET/CT with 18F-DCFPyL versus 18F-Fluorocholine in initial staging of intermediate-/high-risk prostate cancer: a pilot study [J].

Lucas, Cristina Lucas ;

Zoghby, Laura Garcia ;

Amo-Salas, Mariano ;

Castrejon, angel Maria Soriano ;

Vicente, Ana Maria Garcia .

ANNALS OF NUCLEAR MEDICINE, 2023, 37 (10) :551-560

[20] Role of radiomic analysis of [18F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging [J].

Marturano, Francesca ;

Guglielmo, Priscilla ;

Bettinelli, Andrea ;

Zattoni, Fabio ;

Novara, Giacomo ;

Zorz, Alessandra ;

Sepulcri, Matteo ;

Gregianin, Michele ;

Paiusco, Marta ;

Evangelista, Laura .

EUROPEAN RADIOLOGY, 2023, 33 (10) :7199-7208

← 1 2 3 4 5 →